Background Reports of disease and production losses associated with Fasciola hepatica, the common liver fluke, have increased in recent years. Resistance to triclabendazole, one of the principal veterinary medicines used to prevent losses, has been reported and is now considered widespread in fluke endemic regions of the UK.
Methods Thirteen farmers participated in a trial in 2013 and the triclabendazole resistance status was obtained for each farm. Based on these results, a knowledge exchange programme on fluke control was delivered to nearly 100 farmers in the region. In this follow-up study, 11 farmers involved in the original trial, participated in semistructured in-depth qualitative interviews in July 2017.
Results Overall, participants identified benefits from participating in the 2013 trial, gaining information about triclabendazole resistance on their farms and knowledge about fluke control. The information on their farm’s resistance status was a driver for changing their liver fluke control programmes. Factors such as habitual and repetitive behaviours, grazing restrictions due to agri-environmental schemes, economic pressures and climate change were identified that could impede or prevent the adoption of new control strategies.
Conclusions The study highlights the significance of resistance to triclabendazole and the impact of knowledge exchange programmes in changing liver fluke control practices.
- liver fluke
- farm animals
Statistics from Altmetric.com
Funding This study was funded by a University of Liverpool Accelerating Impact Award and the European Union funded DELIVER Project (Contract No.: FOOD-CT-2004–023025).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval Approval for the study was granted by the University of Liverpool Research Ethics Committee, approval number VREC558, and an overview of the study was provided for participants. Signed consent was obtained before the interviews were undertaken.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement No data are available. All available data are included in the manuscript. It is not possible to provide the interview transcripts.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.